1. Home
  2. FTH vs ABX Comparison

FTH vs ABX Comparison

Compare FTH & ABX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

N/A

Current Price

$27.39

Market Cap

835.7M

Sector

Health Care

ML Signal

N/A

Logo Abacus Global Management Inc. Class A Common Stock

ABX

Abacus Global Management Inc. Class A Common Stock

HOLD

Current Price

$8.24

Market Cap

810.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTH
ABX
Founded
N/A
2004
Country
United States
United States
Employees
N/A
326
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
835.7M
810.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FTH
ABX
Price
$27.39
$8.24
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
★ $9.50
AVG Volume (30 Days)
334.0K
★ 514.5K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
★ 2.13%
EPS Growth
N/A
★ 205.88
EPS
N/A
★ 0.14
Revenue
N/A
★ $235,237,636.00
Revenue This Year
N/A
$19.18
Revenue Next Year
N/A
$14.60
P/E Ratio
★ N/A
$59.29
Revenue Growth
N/A
★ 110.18
52 Week Low
$17.50
$7.18
52 Week High
$42.14
$12.44

Technical Indicators

Market Signals
Indicator
FTH
ABX
Relative Strength Index (RSI) 35.69 35.42
Support Level $23.47 $7.25
Resistance Level $36.63 $9.78
Average True Range (ATR) 3.06 0.41
MACD -1.28 -0.09
Stochastic Oscillator 9.12 30.28

Price Performance

Historical Comparison
FTH
ABX

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

About ABX Abacus Global Management Inc. Class A Common Stock

Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The company operates through four distinct yet complementary divisions: Abacus Life Solutions, Abacus Asset Group, Abacus Intel, and Abacus Wealth Advisors. It operates through three reportable segments, Asset management, Life solutions, and Technology services. It derives the majority revenue from Life solutions segment that generates revenues by buying, selling, and trading policies, and maintaining policies until receipt of death benefits. It also generates revenue by originating life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner.

Share on Social Networks: